RocketTickers

Antares Pharma Announces Positive Results From Phase I Study For

Long
NASDAQ:ATRS   None
ATRS: Antares Pharma, Inc.
2022-01-11 07:30:00
Antares Pharma Announces Positive Results From Phase I Study For ATRS-1902 For Adrenal Crisis Rescue
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.